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In obese patients with type 2 diabetes, insulin
delivery to and insulin-dependent glucose uptake
by skeletal muscle are delayed and impaired. The
mechanisms underlying the delay and impairment
are unclear. We demonstrate that impaired insulin
signaling in endothelial cells, due to reduced Irs2
expression and insulin-induced eNOS phosphoryla-
tion, causes attenuation of insulin-induced capillary
recruitment and insulin delivery, which in turn
reduces glucose uptake by skeletal muscle. More-
over, restoration of insulin-induced eNOS phosphor-
ylation in endothelial cells completely reverses the
reduction in capillary recruitment and insulin delivery
in tissue-specific knockoutmice lacking Irs2 in endo-
thelial cells and fed a high-fat diet. As a result,
glucose uptake by skeletal muscle is restored in
these mice. Taken together, our results show that
insulin signaling in endothelial cells plays a pivotal
role in the regulation of glucose uptake by skeletal294 Cell Metabolism 13, 294–307, March 2, 2011 ª2011 Elsevier Inc.muscle. Furthermore, improving endothelial insulin
signaling may serve as a therapeutic strategy for
ameliorating skeletal muscle insulin resistance.
INTRODUCTION
Skeletal muscle is one of the major target organs of insulin
actions and plays an essential role in insulin-induced glucose
uptake (DeFronzo et al., 1979; Bergman, 1989). Insulin, secreted
by the pancreatic b cells, is delivered into the capillaries and
crosses the endothelial barrier to enter the interstitial spaces
(Vincent et al., 2005). It then binds to the insulin receptors on
the skeletal muscle cell surface, activating intracellular pathways
in the skeletal muscle (White and Kahn, 1994; Petersen et al.,
2004; Long and Zierath, 2008). Recent evidence indicates that
insulin delivery to the skeletal muscle interstitium is the rate-
limiting step in insulin-stimulated glucose uptake by the skeletal
muscle, and is much slower in obese insulin-resistant subjects
than in normal subjects (Sherwin et al., 1974; DeFronzo et al.,
1979; Yang et al., 1989; Jansson et al., 1993; Miles et al.,
1995; Sjostrand et al., 2002; Barrett et al., 2009). Andres and
colleagues have shown that insulin is distributed more slowly
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other compartments, and the time course of insulin equilibration
with this pool closely paralleled the glucose infusion rate (GIR) in
their compartmental model (Sherwin et al., 1974; DeFronzo et al.,
1979). Moreover, the dynamics of insulin concentrations in the
skeletal muscle lymphatics, which is derived from the interstitial
fluid in the skeletal muscle, is actually slow, and is significantly
correlated with the peripheral glucose uptake after insulin
infusion (Yang et al., 1989). In obese subjects, the appearance
of insulin in the interstitial fluid of the skeletal muscle and onset
of insulin action after insulin infusion were found to be signifi-
cantly delayed in comparison with the results in control subjects
(Sjostrand et al., 2002). Although the slow onset of insulin action
on glucose disposal in vivo could be secondary to a slow
response by the cellular machinery within the myocytes, which
are the cells responsible for glucose uptake in the skeletal
muscle, insulin-induced glucose uptake by myocytes in vitro
appears to be fully activated within 2–5 min, much earlier than
that in vivo (Karnieli et al., 1981). Moreover, Bergman et al.
demonstrated that injection of insulin directly into the interstitium
of the skeletal muscle is followed by a prompt increase in the
glucose uptake (Chiu et al., 2008). Based on these findings,
insulin delivery may determine the in vivo time course of
insulin-induced glucose uptake, which may be much slower
than the insulin-induced glucose uptake in vitro.
Two discrete steps have been reported to increase insulin
delivery to the skeletal muscle: an increase in the available capil-
lary surface area (capillary recruitment), and an increase in the
transendothelial transport of insulin. Clark and colleagues
measured capillary recruitment following insulin infusion and
found that it was associated with increased glucose uptake by
the skeletal muscle (Rattigan et al., 1997; Vincent et al., 2004).
The insulin-induced capillary recruitment and glucose uptake
were reported to be significantly impaired in obese subjects
and diabetic models (Wallis et al., 2002; Keske et al., 2009).
In addition to the vasoactive actions of insulin on the capillaries,
insulin may promote its own movement across the endothelial
barrier. Recent in vivo evidence suggests that transendothelial
transport of insulin in the skeletal muscle increased along with
elevation of the plasma insulin levels, and that these levels
were diminished in the presence of high-fat (HF) diet-induced
insulin resistance (Hamilton-Wessler et al., 2002; Ellmerer
et al., 2006; Wang et al., 2008). It is still unclear whether capillary
recruitment and transendothelial transport of insulin may be
related or may function independently (Clark, 2008).
We hypothesized that an insulin signaling defect in the endo-
thelial cells impairs insulin-induced capillary recruitment and
insulin delivery in the skeletal muscle in obesity. In HF diet-fed
obese mice, the expression levels of insulin receptor substrate
(Irs)2, which is the major Irs isoform expressed in the endothelial
cells (Kubota et al., 2003), were markedly reduced, and insulin-
induced eNOS phosphorylation, capillary recruitment, and
insulin delivery were markedly impaired. Consistent with these
results, mice with Irs2 deletion in the endothelial cells (ETIrs2KO
mice) also exhibited a reduction of insulin-induced eNOS
phosphorylation, capillary recruitment, and insulin delivery.
Moreover, restoration of the insulin-induced eNOS phosphoryla-
tion in the endothelial cells completely reversed the reduction of
the capillary recruitment and insulin delivery in both the HF diet-Cefed and ETIrs2KO mice. We conclude that a genetically and/or
environmentally induced insulin signaling defect in the endothe-
lial cells causes skeletal muscle insulin resistance as a conse-
quence of the impaired insulin-induced capillary recruitment
and insulin delivery.
RESULTS
Insulin Signaling Was Significantly Impaired in the
Endothelial Cells of the ob/ob and HF Diet-Fed Mice
To investigate insulin signaling in the endothelial cells in mouse
models of obesity, we first measured the expression levels of
the insulin receptor (Ir) and Ir substrate (Irs) in mice with genet-
ically (ob/ob mice) or environmentally induced (8-week HF
diet-fed mice) obesity. Although there were no significant
differences in the mRNA or protein expression levels of Ir and
endothelin (ET)-1 (see Figures S1A and S1B available online),
the mRNA and protein expression levels of Irs1 were reduced
by approximately 50% and those of Irs2, the major Irs isoform
expressed on the endothelial cells (Kubota et al., 2003), by
approximately 80% in the endothelial cells of both the mouse
models of obesity (Figures 1A and 1B). To elucidate the mech-
anisms by which the expressions of Irs1 and Irs2 in the endo-
thelial cells were downregulated, we investigated the effects of
FFA on the expressions of Irs1 and Irs2 following continuous
administration of intralipid for 24 hr in C57Bl/6 mice. Although
a 7-fold increase of the plasma FFA levels was observed after
the intralipid treatment, the expression levels of Irs1 and Irs2
measured before and after the intralipid treatment were not
significantly different (Figure S1C). We next investigated
whether the Irs1 and Irs2 gene expressions in the endothelial
cells might be altered by hyperinsulinemia induced by contin-
uous administration of insulin for 24 hr using a miniosmotic
pump in C57Bl/6 mice. After continuous administration of
insulin for 24 hr, a 7-fold increase of the plasma insulin levels
was noted (Figure 1C). In regard to the expression levels of
the Irs1 and Irs2, on the other hand, while no change in the
expression of endothelial Irs1 was observed, the expression
of endothelial Irs2 was significantly decreased (Figure 1C).
These data suggest that hyperinsulinemia may be one of the
mechanisms underlying the decrease in the expression of
endothelial Irs2 observed in the ob/ob and HF diet-fed mice,
although the reason for the downregulated Irs1 expression in
these mice still remains unexplained. The insulin signaling
cascade activates Akt, which in turn phosphorylates and acti-
vates eNOS in the endothelial cells (Muniyappa and Quon,
2007). Consistent with the results for the expression levels of
Irs1 and Irs2, insulin-stimulated phosphorylations of Akt and
eNOS were decreased by 70%–80% in the endothelial cells
of the ob/ob and HF diet-fed mice (Figure 1D), indicating that
insulin signaling was impaired in the endothelial cells of these
obesity models. We then investigated whether impaired insulin
signaling in the endothelial cells might be involved in the HF
diet-induced, obesity-linked impairment of glucose uptake by
the skeletal muscle. Although an increase of the capillary blood
volume at 10 min after the insulin infusion in the hyperinsuline-
mic-euglycemic clamp study was observed in the normal
chow-fed mice, no such increase was observed in the HF
diet-fed mice (Figure 1E). On the other hand, no increase ofll Metabolism 13, 294–307, March 2, 2011 ª2011 Elsevier Inc. 295
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Figure 1. In the HF Diet-Fed Obese Mice, which Show Impaired Glucose Uptake by the Skeletal Muscle, Decreased Insulin-Induced
Phosphorylation of eNOS in the Endothelial Cells, along with Downregulation, Mainly of Irs2, Was Associated with Attenuation of the
Insulin-Induced Increase of the Capillary Blood Volume and of the Increase of the Interstitial Concentrations of Insulin
(A and B) Expression levels of Irs1 or Irs2 mRNA and protein in the endothelial cells of the ob/ob and HF diet-fed mice (n = 3–11).
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after the insulin infusion in either the normal chow-fed or the HF
diet-fed mice (Figure 1F). These data suggest that capillary
recruitment starts to increase well before the increase of the
interstitial insulin concentrations, consistent with the results of
previous studies (Miles et al., 1995; Vincent et al., 2005).
Insulin-induced increases of the capillary blood volume and
interstitial concentrations of insulin were significantly impaired
at 60 and 120 min after the insulin infusion in the hyperinsuline-
mic-euglycemic clamp study (Figures 1E and 1F; Movies S1A
and S1B, and data not shown), even when the plasma insulin
levels were adjusted to be the same in both the normal
chow-fed and HF diet-fed mice (Figure S1D and data not
shown). A significant decrease of the GIR and glucose disap-
pearance rate (Rd), as also a significant increase of the endog-
enous glucose production (EGP), were found in the animals at
60 and 120 min after the insulin infusion in the hyperinsuline-
mic-euglycemic clamp study (Figure 1G and data not shown).
Consistent with these results, the phosphorylation levels of
Akt in the skeletal muscle in the normal chow-fed mice began
to increase by 30 min and reached its peak about 60 min after
the insulin infusion, whereas this increase of the Akt phosphor-
ylation level from 30 min onward after the insulin infusion in the
hyperinsulinemic-euglycemic clamp study was significantly
impaired in the HF diet-fed mice (Figure 1H; Figure S1E and
data not shown). These data suggest that the decreased phos-
phorylation level of eNOS induced by insulin in the endothelial
cells associated with downregulation, mainly of Irs2, appears to
be involved, along with the impaired insulin-induced capillary
recruitment and increase of the interstitial concentrations of
insulin, in the impaired glucose uptake by the skeletal muscle
in the HF diet-fed obese mice.
ETIrs2KO Mice Exhibited Impaired Insulin-Induced
Glucose Uptake by the Skeletal Muscle
In order to elucidate the causal relationship between insulin
signaling in the endothelial cells and the glucose uptake by the
skeletal muscle, we generated ETIrs2KO mice. The endothelial
Irs2 mRNA levels were reduced by approximately 95% in the
ETIrs2KO mice, whereas the Irs2 expression levels in the white
adipose tissue (WAT), liver, and skeletal muscle remained
unchanged (Figures 2A and 2B). The Irs2 protein expression
and insulin-stimulated tyrosine phosphorylation of Irs2 were
almost completely abrogated in the endothelial cells of the
ETIrs2KOmice (Figure 2C). There were no significant differences
in the mRNA and protein levels of eNOS or ET-1 between the
control and ETIrs2KO mice (Figures S2A and S2B). The basal
blood glucose and plasma insulin levels were indistinguishable
between the control and ETIrs2KO mice (Figure S2C). Insulin-
stimulated phosphorylations of Akt and eNOS were found to
be significantly reduced in the endothelial cells of the ETIrs2KO(C) Expression levels of Irs1 and Irs2 mRNA after insulin infusion (n = 3–4).
(D) Phosphorylation levels of Akt and eNOS in the ob/ob and HF diet-fed mice (n
(E and F) Capillary blood volume (E) and interstitial insulin levels (F) in the HF die
(G) GIR, EGP, and Rd in the HF diet-fed mice after insulin infusion in the hyperin
(H) Phosphorylation levels of Akt (ser473) in the skeletal muscle of the HF diet-f
(n = 3–4). ‘‘NC’’ indicates normal chow-fed mice. ‘‘NA’’ indicates not applica
*p < 0.05, **p < 0.01, ***p < 0.001.
Cemice (Figure 2D). Although an increase of the capillary blood
volume was observed in the control mice by 10 min after the
insulin infusion in the hyperinsulinemic-euglycemic clamp study,
no such increasewas observed in the ETIrs2KOmice (Figure 2E).
In contrast, no increase in the interstitial concentrations of insulin
was observed at 10 min after the insulin infusion in either the
control or the ETIrs2KO mice (Figure 2F). The insulin-induced
increases of the capillary blood volume and interstitial concen-
trations of insulin were significantly impaired at 60 and 120 min
after insulin infusion in the hyperinsulinemic-euglycemic clamp
study (Figures 2E and 2F and data not shown), even when the
plasma insulin levels were adjusted to be the same in both the
control and ETIrs2KO mice (Figure S2D and data not shown).
Furthermore, the whole-body insulin sensitivity and glucose
tolerance were also significantly impaired in the ETIrs2KO mice
(Figures 2G and 2H). The GIR and Rd at 60 and 120 min after
insulin infusion in the hyperinsulinemic-euglycemic clamp study
were significantly reduced in the ETIrs2KO mice (Figure 2I and
data not shown). The decreased Rd observed in the ETIrs2KO
mice during the hyperinsulinemic-euglycemic clamp, however,
indicates impairment of glucose uptake by mainly the skeletal
muscle, but also by other tissues containing nonfenestrated
endothelial cells forming tight junctions. Thus, we also measured
the insulin-induced glucose uptake by the skeletal muscle
during the hyperinsulinemic-euglycemic clamp study using
2-deoxy-[3H]glucose (2-[3H]DG). Consistent with the results
obtained for the Rd, the skeletal muscle glucose uptake was
significantly reduced in the ETIrs2KO mice (Figure 2J), suggest-
ing that the glucose uptake through the capillaries, at least, was
impaired in the skeletal muscle of the ETIrs2KOmice. In contrast,
glucose uptake by the isolated skeletal muscle from the
ETIrs2KO mice was not impaired (Figure 2K), indicating that
glucose uptake by the skeletal muscle per se was not impaired
in the ETIrs2KO mice. Consistent with these results, the phos-
phorylation level of Akt in the skeletal muscle in the control
mice began to increase by 30 min and reached its peak about
60 min after insulin infusion in the hyperinsulinemic-euglycemic
clamp study, whereas this increase in the Akt phosphorylation
level was significantly impaired in the ETIrs2KO mice (Figure 2L;
Figure S2E and data not shown). Moreover, the phosphorylation
levels of Irb, as well as those of Irs1 and Akt, in the skeletal
muscle were also significantly decreased in the ETIrs2KO mice
at 60 min after insulin infusion into the inferior vena cava
(Figure S2F). In contrast, no significant differences in the phos-
phorylation levels of Irb, Irs1, Irs2, or Akt in the liver were
observed between the control and ETIrs2KO mice (Figure S2G),
even though Irs2 was also deleted from the hepatic endothelial
cells of the ETIrs2KO mice (Figure S2H). Quantitative analysis
revealed no significant difference in the b cell mass between
the control and ETIrs2KO mice (Figure S2I). These data suggest
that Irs2 deletion in the endothelial cells causes an insulin= 4-7).
t-fed mice (n = 3–10).
sulinemic-euglycemic clamp study (n = 7–9).
ed mice after insulin infusion in the hyperinsulinemic-euglycemic clamp study
ble. Where error bars are shown, the results represent the means ± SEM.
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Endothelial Insulin Signal and Glucose Metabolismsignaling defect in the cells that results in impairment of insulin-
induced eNOS phosphorylation, capillary recruitment, and
increase of the interstitial concentrations of insulin, consequently
impairing the skeletal muscle glucose uptake.
Insulin-Induced Glucose Uptake by the Skeletal Muscle
Was Not Impaired in the ETIrs1KO Mice, but Was
Significantly Reduced in the ETIrs1/2DKO Mice,
as Compared with that in the ETIrs2KO Mice
To investigate the role of Irs1 expressed in the endothelial cells in
the regulation of insulin-induced glucose uptake by the skeletal
muscle, we generated mice with endothelial-cell-specific Irs1
knockout (ETIrs1KO mice). Although the Irs1 mRNA and protein
levels were almost completely abrogated in the endothelial
cells of the ETIrs1KO mice (Figures 3A and 3B), no significant
differences in the expression levels of Irs2, eNOS, or ET-1
mRNA and protein were observed between the control and
ETIrs1KO mice (Figures 3A and 3B). No significant difference in
the insulin-stimulated phosphorylation levels of Akt or eNOS
was observed between the control and ETIrs1KO mice (Fig-
ure 3C). Furthermore, no significant differences in the results
of the insulin tolerance test or glucose tolerance test were
observed between the control and ETIrs1KO mice (Figures 3D
and 3E). Consistent with these results, there were also no
significant differences in the results of the hyperinsulinemic-
euglycemic clamp study between the control and ETIrs1KO
mice (Figure 3F).
We next generated mice with endothelial-cell-specific Irs1/
Irs2 double-knockout (ETIrs1/2DKO), in an attempt to elucidate
whether insulin signaling in the endothelial cells might be exclu-
sively mediated by Irs1 and Irs2. Although the Irs1 and Irs2
mRNA and protein levels were almost completely abrogated in
the endothelial cells of the ETIrs1/2DKO mice (Figures 3G and
3H), no significant differences in the mRNA or protein levels of
eNOS and ET-1 were observed between the control and
ETIrs1/2DKO mice (Figures 3G and 3H). The insulin-stimulated
phosphorylation levels of Akt and eNOS were significantly
reduced in the ETIrs1/2DKO mice (Figure 3I). The insulin toler-
ance test revealed that the glucose-lowering effect of insulin
was significantly attenuated in the ETIrs1/2DKOmice (Figure 3J),
and the glucose tolerance test revealed significantly elevated
plasma glucose levels in the ETIrs1/2DKO mice (Figure 3K).
Moreover, the GIR and Rd in the ETIrs1/2DKO mice were signif-
icantly reduced as compared with the values not only in theFigure 2. Irs2 Deletion in the Endothelial Cells Caused an Insulin Signali
the Capillary Blood Volume and Interstitial Concentrations of Insulin
Muscle
(A) Expression levels of Irs1 and Irs2 mRNA in the endothelial cells of the WT, Tie
(B) The expression levels of Irs2 in the WAT, liver, and skeletal muscle of the WT
(C) Insulin-stimulated tyrosine phosphorylation levels of Irb, Irs1, and Irs2 in the e
(D) Phosphorylation levels of Akt and eNOS in the endothelial cells of the ETIrs2K
(E and F) Capillary blood volume (E) and interstitial insulin levels (F) in the ETIrs2
(G and H) Insulin tolerance test (G) and glucose tolerance test (H) in the ETIrs2KO
(I) GIR, EGP, and Rd in the ETIrs2KO mice after insulin infusion in the hyperinsul
(J) Glucose uptake by the skeletal muscle in the ETIrs2KO mice after insulin infu
(K) Glucose uptake by the isolated skeletal muscle in the ETIrs2KO mice (n = 3).
(L) Phosphorylation levels of Akt (ser473) in the skeletal muscle of the ETIrs2KO
(n = 3–4). ‘‘Control’’ indicates Irs2lox/lox mice. ‘‘NA’’ indicates not applicable. Wh
**p < 0.01, ***p < 0.001.
Cecontrol mice but also in the ETIrs2KO mice (Figure 3L). These
data suggest that Irs1 may play a significant role in endothelial
cell insulin signaling, which becomes evident especially when
Irs2 expression is downregulated, such as in the ETIrs2KO and
HF diet-fed mice.
Restoration of Insulin-Induced eNOS Phosphorylation
in the Endothelial Cells Restored Glucose Uptake
by the Skeletal Muscle in the ETIrs2KO Mice
To determine whether restoration of the insulin-induced eNOS
phosphorylation in the endothelial cells might restore the
glucose uptake by the skeletal muscle, we administered bera-
prost sodium (BPS), a stable prostaglandin (PGI)2 analog (Kainoh
et al., 1991), to the ETIrs2KO mice; this agent has been reported
to increase the expression levels of eNOS mRNA and protein
through the cyclic adenosine monophosphate (cAMP)-, protein
kinase A-, and cAMP-responsive element-mediated pathways
(Niwano et al., 2003). Indeed, this treatment increased the
eNOS mRNA and protein expression levels in the endothelial
cells (Figures 4A and 4B). BPS treatment restored insulin-
induced phosphorylation of eNOS in the BPS-treated ETIrs2KO
mice to a level similar to that observed in the saline-treated
control mice (Figure 4B), despite the absence of any change in
the ratio of phosphorylated eNOS to total eNOS (Figure 4B);
also, no change in the insulin-induced phosphorylation of Akt
was observed in these mice (Figure S3A). The insulin-induced
increase of the capillary blood volume and interstitial concentra-
tions of insulin were restored at 60 and 120 min after insulin
infusion in the hyperinsulinemic-euglycemic clamp study
(Figures 4C and 4D and data not shown) under comparable
plasma insulin concentrations (Figure S3B and data not shown).
The restoration of the insulin-induced increase of the capillary
blood volume by BPS treatment in the ETIrs2KO mice was
completely blocked by administration of the NOS inhibitor, NG-
nitro-L-arginine methyl ester (L-NAME) (Figure 4E), suggesting
that the restoration of the insulin-induced capillary recruitment
by BPS treatment was eNOS dependent. To rule out the possi-
bility that BPS and L-NAME regulated the skeletal muscle
glucose uptake through an eNOS-independent mechanism, we
next administered BPS and L-NAME to eNOS-knockout
(eNOSKO) mice. There were no significant differences in the
insulin-induced increases of the capillary blood volume or inter-
stitial insulin concentrations among the saline-treated, BPS-
treated, and L-NAME-treated eNOSKO mice, either at the basalng Defect Resulting in a Reduction of the Insulin-Induced Increase of
and, as a Consequence, Impaired Glucose Uptake by the Skeletal
2-Cre, Irs2lox/lox, and ETIrs2KO mice (n = 4–8).
, Tie2-Cre, Irs2lox/lox, and ETIrs2KO mice (n = 5–6).
ndothelial cells of the ETIrs2KO mice.
O mice (n = 8–12).
KO mice (n = 3–10).
mice (n = 8–10).
inemic-euglycemic clamp study (n = 3–9).
sion in the hyperinsulinemic-euglycemic clamp study (n = 3–9).
mice after insulin infusion in the hyperinsulinemic-euglycemic clamp study
ere error bars are shown, the results represent the means ± SEM. *p < 0.05,
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Figure 3. In the ETIrs1/2DKO, but Not ETIrs1KO, Mice, the GIR and Rd Were Significantly Reduced as Compared with the Values Seen Not
Only in the Control Mice, But Also in the ETIrs2KO Mice, in Addition to the Impairment of Insulin Signaling in the Endothelial Cells, Whole-
Body Insulin Sensitivity, and Glucose Tolerance
(A and B) Expression levels of Irs1, Irs2, eNOS, or ET-1 mRNA and protein in the endothelial cells of the ETIrs1KO mice (n = 3–6).
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Endothelial Insulin Signal and Glucose Metabolismor at 60 min after insulin infusion (Figures S3C and S3D). More-
over, there were no significant differences in the results of the
insulin tolerance or glucose tolerance tests, or in the skeletal
muscle glucose uptake among the three groups (Figures S3E–
S3G). These data strongly suggest that the effects of both BPS
and L-NAME were eNOS dependent. The GIR and Rd were
completely restored in the BPS-treated ETIrs2KO mice at 60
and 120min after insulin infusion (Figure 4F and data not shown).
We also measured the glucose uptake by the skeletal muscle
after insulin infusion in the hyperinsulinemic-euglycemic clamp
study. Glucose uptake by the skeletal muscle after insulin infu-
sion was completely restored in the BPS-treated ETIrs2KO
mice (Figure 4G). On the other hand, the glucose uptake by the
isolated skeletal muscle from theBPS-treated ETIrs2KOmice re-
mained essentially unchanged (Figure 4H), indicating the
absence of any significant effect of BPS treatment on the
glucose uptake by the skeletal muscle per se. Consistent with
the results for the interstitial insulin concentrations, the phos-
phorylation levels of Irb, as well as those of Irs1 and Akt, in the
skeletal muscle were also completely restored in the BPS-
treated ETIrs2KO mice at 60 min after insulin infusion into the
inferior vena cava (Figure S3H). These data suggest that restora-
tion of the insulin-induced phosphorylation of eNOS in the endo-
thelial cells also restored the insulin-induced capillary recruit-
ment and increase of the interstitial concentrations of insulin,
consequently restoring the insulin-induced glucose uptake by
the skeletal muscle. Alternatively, there is also the possibility
that concomitant BPS plus insulin treatment activated eNOS
via a pathway independent of the insulin/Irs/Akt pathway, even
though BPS alone had no effect on eNOS phosphorylation. No
significant differences were observed in the food intake, body
weight, or weights of the visceral and subcutaneous fat pads
among the three groups (Figure S4A). No significant differences
in the plasma lipid profile or expression levels of adipokines were
observed either among the three groups (Figures S4B and S4C).
No significant difference in the 2-[3H]DG uptake by the skeletal
muscle was noted between the saline- and L-NAME-treated
control mice (Figure S4D).
Restoration of Insulin-Induced eNOS Phosphorylation in
the Endothelial Cells Restored the Glucose Uptake by
the Skeletal Muscle in the HF Diet-Fed Mice
Could the restoration of insulin-induced eNOS phosphorylation
in the endothelial cells also ameliorate the impaired glucose
uptake by the skeletal muscle in the HF diet-fed obese mice?
BPS treatment significantly increased the eNOS mRNA (Fig-
ure 5A) and protein (Figure 5B) expression levels. BPS treatment
in the HF diet-fed mice restored insulin-induced phosphorylation
of eNOS to a level similar to that observed in the saline-treated(C) Insulin-stimulated phosphorylation levels of Akt and eNOS in the endothelial
(D and E) Insulin tolerance test (D) and glucose tolerance test (E) in the ETIrs1KO
(F) GIR, EGP, and Rd in the ETIrs1KO mice during the hyperinsulinemic-euglyce
(G and H) Expression levels of Irs1, Irs2, eNOS, and ET-1 mRNA and protein in t
(I) Insulin-stimulated phosphorylation levels of Akt and eNOS in the endothelial c
(J and K) Insulin tolerance test (J) and glucose tolerance test (K) in the ETIrs1/2D
(L) GIR, EGP, and Rd in the ETIrs1/2DKO mice during the hyperinsulinemic-eugly
mice; ‘‘Control’’ ETIrs1/2DKO mice indicates Irs1lox/lox/Irs2lox/lox mice. Where erro
***p < 0.001.
Cenormal chow-fed mice (Figure 5B), despite the absence of any
change in the ratio of phosphorylated eNOS to total eNOS in
the BPS-treated HF diet-fed mice (Figure 5B); also, no change
in the insulin-induced phosphorylation of Akt was observed in
these mice (Figure S5A). These data suggest that restoration of
the insulin-induced eNOS phosphorylation in the BPS-treated
HF diet-fed mice was not due to improvement of insulin
signaling, but was rather proportional to the protein expression
levels of eNOS. The decreased capillary blood volume and inter-
stitial concentrations of insulin observed in the saline-treated HF
diet-fed mice were restored at 60 and 120 min after insulin infu-
sion in the BPS-treated HF diet-fed mice (Figures 5C and 5D and
data not shown), when the plasma insulin levels were adjusted to
be the same among the three groups (Figure S5B and data not
shown). The restoration of the capillary blood volume by BPS
treatment at 60 min after insulin infusion in the HF diet-fed
mice was completely blocked by L-NAME treatment (Figure 5E).
Consequently, the GIR and Rd at 60 and 120 min after insulin
infusion were significantly, but not completely, restored by
BPS treatment, although the increased EGP remained
unchanged (Figure 5F and data not shown). We also measured
the skeletal muscle glucose uptake after insulin infusion in the
hyperinsulinemic-euglycemic clamp study. Glucose uptake by
the skeletal muscle after insulin infusion was significantly, but
not completely, restored in the BPS-treated HF diet-fed mice
(Figure 5G). On the other hand, the glucose uptake by isolated
skeletal muscle from the HF diet-fed mice treated with BPS re-
mained essentially unchanged (Figure 5H), indicating the
absence of any significant effect of BPS treatment on the
glucose uptake by the skeletal muscle per se. Consistent with
the results for the interstitial insulin concentrations, the insulin-
induced phosphorylation levels of Irb, as well as those of Irs1
and Akt, in the skeletal muscle at 60 min after insulin infusion
into the inferior vena cava were significantly, but not completely,
restored in the BPS-treated HF diet-fedmice (Figure S5C). More-
over, the increase in the blood glucose after glucose loading was
significantly, but not completely, ameliorated during an oral
glucose tolerance test conducted after BPS treatment in the
HF diet-fed mice (Figure S5D). No significant differences in the
food intake, body weight, or weights of the visceral and subcuta-
neous fat pads were noted between the saline- and BPS-treated
HF diet-fed mice (Figure S5E). No significant differences in the
plasma lipid profile or expression levels adipokines were noted
between the saline- and BPS-treated HF diet-fed mice (Figures
S5F and S5G). Taken together, restoration of insulin-induced
eNOS activation in the endothelial cells restored the insulin-
induced capillary recruitment and interstitial insulin concentra-
tions, resulting in improvement of the skeletal muscle glucose
uptake in the HF diet-fed obese mice.cells of the ETIrs1KO mice (n = 3–5).
mice (n = 6).
mic clamp study (n = 6–8).
he endothelial cells of the ETIrs1/2DKO mice (n = 3–6).
ells of the ETIrs1/2DKO mice (n = 5–6).
KO mice (n = 8–9).
cemic clamp study (n = 5–10). ‘‘Control’’ of ETIrs1KO mice indicates Irs1lox/lox
r bars are shown, the results represent the means ± SEM. *p < 0.05, **p < 0.01,
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Figure 4. Restoration of the Insulin-Induced Phosphorylation of eNOS in the Endothelial Cells Restored the Insulin-Induced Increase of the
Capillary Blood Volume and Interstitial Concentrations of Insulin; as a Consequence, the Insulin-Induced Glucose Uptake by the Skeletal
Muscle Was Also Restored in the ETIrs2KO Mice
(A–D) eNOS mRNA levels (A), insulin-stimulated phosphorylation level of eNOS (B), capillary blood volume (C), and interstitial insulin concentrations (D) in the
BPS-treated ETIrs2KO mice (n = 5–8).
(E) Capillary blood volume in the BPS-treated ETIrs2KO mice following L-NAME treatment (n = 4–6).
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In this study, we demonstrated that endothelial insulin signaling
is also significantly impaired in HF diet-fed mice, as in the other
target organs of insulin, such as the liver and skeletal muscle.
Moreover, insulin-induced capillary recruitment, increase of
interstitial insulin concentrations, and glucose uptake were
also significantly decreased in the skeletal muscle, all of which
were reversed by restoration of the insulin-induced phospholyra-
tion of eNOS in the endothelial cells. These data suggest that
impaired insulin signaling in the endothelial cells, with reduction
of Irs2 expression and insulin-induced eNOS phosphorylation,
reduces insulin-induced glucose uptake by the skeletal muscle
via, at least in part, decreased capillary recruitment and
decreased interstitial insulin concentrations in the skeletal
muscle. In fact, an insulin signaling defect induced by Irs2 dele-
tion from the endothelial cells caused impaired insulin-induced
glucose uptake by the skeletal muscle, along with attenuation
of the insulin-induced capillary recruitment and increase of inter-
stitial insulin concentrations.
Based on these data, we provide insight into themechanism of
insulin resistance in the skeletal muscle (Figure 6). Since the
plasma insulin levels of lean subjects are low, and the expression
levels of Irs2 in their endothelial cells are presumably maintained
under the fasting condition, insulin-mediated Akt and eNOS
activations are induced optimally after feeding, resulting in
insulin-induced capillary recruitment, increase of interstitial
insulin concentrations, and increase of glucose uptake by the
skeletal muscle. By contrast, since downregulation of Irs2
expression is probably induced by hyperinsulinemia in the endo-
thelial cells of obese subjects, the insulin-mediated Akt and
eNOS activations after feeding are inadequate, and as a result,
insulin-induced capillary recruitment, increase of interstitial
insulin concentrations, and increase of glucose uptake by the
skeletal muscle are impaired in obese subjects. This insight
into the mechanism also sheds light on the physiological roles
of Irs2 in the endothelial cells. Expression of a sufficient amount
of Irs2 in the endothelial cells appears to be critical to normal
glucose homeostasis. When Irs2 expression is abundant in the
fasting state, adequate glucose uptake by the skeletal muscle
is induced and the elevated glucose levels return to within the
normal range after feeding. However, when Irs2 expression in
the endothelial cells is reduced in the fasting state in the pres-
ence of hyperinsulinemia with insulin resistance, insulin signaling
is impaired, and the elevated glucose levels after feeding fail to
decrease efficiently, and in fact, the ETIrs2KO mice actually ex-
hibited glucose intolerance in the glucose tolerance test
(Figure 2H).
Insulin normally induces both vasorelaxation and vasocon-
striction: insulin-induced vasorelaxation is mediated by the Irs-
PI3K-Akt pathway increasing endothelial NO production, and
insulin-induced vasoconstriction is mainly mediated by the
Shc/SOS/Ras-MAPK pathway inducing ET-1 expression(F) GIR, EGP, and Rd in the BPS-treated ETIrs2KO mice after insulin infusion in t
(G) Glucose uptake by the skeletal muscle in the BPS-treated ETIrs2KO mice aft
(H) Glucose uptake by the isolated skeletal muscle in the BPS-treated ETIrs2KO
results represent the means ± SEM. *p < 0.05, **p < 0.01, ***p < 0.001.
Ce(Muniyappa and Quon, 2007). While insulin-induced eNOS acti-
vation was significantly decreased in the endothelial cells of both
the ETIrs2KO and ETIrs1/2DKO mice (Figures 2D and 3I), the
ET-1 expressions remained unchanged in both models in this
study, indicating that insulin signaling was selectively impaired
in the endothelial cells of these mice (Figures 3G and 3H; Figures
S2A and S2B). This selective insulin signaling defect appears to
be critical to the impairment of the insulin-induced glucose
uptake by the skeletal muscle. In fact, endothelial-cell-specific
insulin receptor-knockout (VENIRKO) mice, in which both the
Irs-PI3K-Akt-eNOS and Shc/SOS/Ras-MAPK-ET-1pathways
are disrupted, do not exhibit skeletal muscle insulin resistance
(Vicent et al., 2003). Moreover, King et al. demonstrated that
while the MAPK activity in the microvessels of obese Zucker
rats remained unchanged, the Irs1 protein and Irs1-associated
PI3kinase activity were modestly reduced, and the Irs2 protein
and Irs2-associated PI3kinase activity were reduced even
further (Jiang et al., 1999). Furthermore, VENIRKO mice devel-
oped insulin resistance when fed either low- or high-salt diets.
These data suggest that the Irs-PI3K-Akt pathway may be
more susceptible to the adverse effects of conditions such as
obesity and dietary salt intake.
ETIrs2KO mice showed glucose intolerance, insulin resis-
tance, and impaired glucose uptake by the skeletal muscle
in vivo (Figures 2G–2J), despite the skeletal muscle per se not
showing impaired insulin-induced glucose uptake (Figure 2K).
In contrast, although myocyte-specific insulin receptor-
knockoutmice exhibited impaired glucose uptake by the skeletal
muscle per se, as glucose uptake by insulin was decreased in the
isolated skeletal muscle, the glucose tolerance and insulin sensi-
tivity were almost normal in vivo (Bru¨ning et al., 1998). Why did
the ETIrs2KO, but not MIRKO, mice show skeletal muscle insulin
resistance in vivo? It has been reported that there are mainly two
different pathways of physiological glucose uptake by the skel-
etal muscle: one mediated in an insulin-dependent manner,
such as after a meal, and the other in an insulin-independent
manner, such as during exercise (Clark, 2008). Considering the
phenotype of the MIRKO mice, the glucose uptake in the
myocytes showing defective expression of the insulin receptor
throughout growth and development may be largely compen-
sated for by insulin-receptor-independent glucose uptake
mechanisms. There may be little such compensatory mecha-
nisms for glucose uptake in the ETIrs2KO mice, which show
adequate expression of the insulin receptor in the skeletal
muscle. Consequently, these mice may exhibit impairment of
insulin-induced glucose uptake by the skeletal muscle, unlike
the MIRKO mice.
To what degree is the impaired insulin delivery induced by the
endothelial insulin signaling defect involved in the skeletal
muscle insulin resistance in obesity and type 2 diabetes?
Glucose uptake by the skeletal muscle was restored by 50%
or more with improvement of the endothelial insulin signaling
and insulin delivery in HF diet-fed mice (Figures 5B and 5G).he hyperinsulinemic-euglycemic clamp study (n = 4–8).
er insulin infusion in the hyperinsulinemic-euglycemic clamp study (n = 4–8).
mice (n = 3–6). ‘‘NA’’ indicates not applicable. Where error bars are shown, the
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Figure 5. Restoration of the Insulin-Induced Phosphorylation of eNOS Restored the Insulin-Induced Increase of the Capillary Blood Volume
and Interstitial Insulin Concentrations, Resulting in Improvement of the Glucose Uptake by the Skeletal Muscle in the HF Diet-Fed Obese
Mice
(A–D) eNOS mRNA levels in the endothelial cells (A), insulin-stimulated phosphorylation level of eNOS (B), capillary blood volume (C), and interstitial insulin
concentrations (D) in the BPS-treated HF diet-fed mice (n = 5–8).
(E) Capillary blood volume in the BPS-treated HF diet-fed mice following L-NAME treatment (n = 4–6).
(F) GIR, EGP, and Rd in the BPS-treated HF diet-fed mice after insulin infusion in the hyperinsulinemic-euglycemic clamp study (n = 3–5).
(G) Glucose uptake by the skeletal muscle in the BPS-treated HF diet-fed mice after insulin infusion in the hyperinsulinemic-euglycemic clamp study (n = 3–5).
(H) Glucose uptake by the isolated skeletal muscle in the BPS-treated HF diet-fed mice (n = 3–5). ‘‘NC’’ indicates normal chow-fed mice. ‘‘NA’’ indicates not
applicable. Where error bars are shown, the results represent the means ± SEM. *p < 0.05, **p < 0.01, ***p < 0.001.
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Figure 6. Impaired Insulin Signaling in the Endothelial Cells Reduces
Insulin-Induced Glucose Uptake by the Skeletal Muscle in Obese
Subjects
In lean subjects, the insulin-mediated Akt and eNOS activations are induced
optimally in the endothelial cells after feeding, resulting in insulin-induced
capillary recruitment, increase of interstitial insulin concentrations, and
increase of the glucose uptake by the skeletal muscle. By contrast, since
the insulin-mediated Akt and eNOS activations are inadequate in the endothe-
lial cells of obese subjects after feeding, the insulin-induced capillary recruit-
ment, increase or interstitial insulin concentrations, and increase of glucose
uptake by the skeletal muscle are impaired.
Cell Metabolism
Endothelial Insulin Signal and Glucose MetabolismMoreover, insulin delivery into the interstitial fluid is known to be
delayed in insulin resistance (Sjostrand et al., 2002), as also is the
onset of insulin stimulation of glucose uptake (Nolan et al., 1997).
In addition, delivery of inulin, a molecule whosemolecular weight
is similar to that of insulin, to the skeletal muscle was reported to
be markedly diminished in diet-induced insulin resistance (Ell-
merer et al., 2006). These findings suggest that impairment of
insulin delivery, possibly caused by an endothelial insulin
signaling defect, may play a critical role in the skeletal muscle
insulin resistance seen in obesity.
Why were decreased insulin signaling and decreased glucose
uptake in response to insulin observed only in the skeletal
muscle of the ETIrs2KOmice and not in their liver? The difference
between the types of capillaries in the liver and skeletal muscle
may explain these differences in the insulin sensitivity of the
two organs. It is thought that the occluded junctions of the
endothelial cells of the capillaries in the skeletal muscle may
prevent paracellular transport of most macromolecules,
including insulin, whereas the fenestrated endothelium of the
capillaries in the liver freely permits paracellular passage of
macromolecules (Aird, 2007). In fact, more rapid insulin action
kinetics have been observed in the liver than in the skeletal
muscle (Sherwin et al., 1974).
Insulin-induced phosphorylation of Akt and eNOS in the
ETIrs2KO mice was significantly, but not completely, impaired
by endothelial Irs2 deficiency (Figure 2D), suggesting the impor-
tant role of both Irs2 and Irs1 in this signaling in the endothelial
cells. In fact, phosphorylation of Akt and eNOS was completely
abrogated in the ETIrs1/2DKO mice (Figure 3I). Thus, in the
physiological state, it is likely that insulin-stimulated Irs1-medi-
ated Akt activates eNOS in proportion to the amount of eNOS
protein available in these mice.CeIn this study, we found that endothelial insulin signaling medi-
ates insulin-stimulated capillary recruitment and increase of
interstitial insulin concentrations and, as a consequence, facili-
tates glucose uptake by the skeletal muscle. Skeletal muscle
insulin resistance may be caused by impaired insulin signaling
not only in the myocytes but also in the endothelial cells. Taken
together, treatment directed at improving insulin signaling in
the endothelial cells as well as myocytes may serve as a thera-
peutic strategy for ameliorating skeletal muscle insulin
resistance.
EXPERIMENTAL PROCEDURES
Mice
ETIrs1KO or ETIrs2KO mice were generated by mating Irs1lox/+ or Irs2lox/+
female mice (Kubota et al., 2008) with transgenic mice expressing Cre under
control of the murine Tie2 promoter (Tie2-Cre mice) (Kisanuki et al., 2001).
The Irs1lox/+:Tie2-Cre or Irs2lox/+:Tie2-Cre male offspring were then
crossed with Irs1lox/+ or Irs2lox/+ female mice to obtain WT (Irs1+/+), Tie2-Cre
(Irs1+/+:Tie2-Cre), control (Irs1lox/lox), and ETIrs1KO (Irs1lox/lox:Tie2-Cre) mice,
or WT (Irs2+/+), Tie2-Cre (Irs2+/+:Tie2-Cre), control (Irs2lox/lox), and ETIrs2KO
(Irs2lox/lox:Tie2-Cre) mice, respectively. To generate endothelial-specific Irs1/
Irs2 double-knockout (ETIrs1/2DKO) mice, Irs1lox/+:Tie2-Cre or Irs2lox/+:Tie2-
Cre male mice were crossed with Irs2lox/+ or Irs1lox/+ female mice, and the
resultant Irs1lox/+/Irs2lox/+:Tie2-Cre male mice were crossed with Irs1lox/+/
Irs2lox/+ female mice. Irs1lox/lox/Irs2lox/lox mice were used as the control for
ETIrs1/2DKO mice. Only male littermates were used for this study; we
did not use the female Tie2-Cre, Irs1lox/+:Tie2-Cre, Irs2lox/+:Tie2-Cre,
Irs1lox/+/Irs2lox/+:Tie2-Cre, ETIrs1KO, ETIrs2KO, or ETIrs1/2DKO mice for
breeding. Further information is provided in the Supplemental Information.
The animal care and experimental procedures used in this study were
approved by the Animal Care Committee of the University of Tokyo.
Capillary Blood Volume
The capillary blood volume was measured by contrast-enhanced ultrasound,
as described previously (Vincent et al., 2004), with some modifications. The
hindlimb muscles were imaged in the short axis using a 40 MHz transducer
(RMV 704) connected to an ultrasound system (Vevo 770; VISUALSONICS
Inc.). Sonazoid (Daiichi Sankyo Corporation) was infused into the animals,
which were divided into three groups for the measurements at 0, 10, and
60 min after the hyperinsulinemic-euglycemic clamp, a high-power ultrasound
with a frequency of 1MHz was applied to the lower leg muscles, and images
were collected for 30 s to assess the enhancement. The ultrasound intensity
in decibels within the region of interest was converted to the acoustic intensity
after background subtraction using 0.5 s ultrasound images, and the micro-
vascular volume, fill rate constant, and capillary blood volume were calculated
according to the equation y = A(1 ebt). Further information is provided in the
Supplemental Information.
Interstitial Concentrations of Insulin in the Skeletal Muscle
Muscle microdialysis was performed in the hindlimb muscles using a 4 mm
microdialysis tubing (CMA-20) at the rate of 0.3 ml/min. We conducted calibra-
tion using the no-net flux technique described previously (Jansson et al.,
1993), with slight modifications. Briefly, four known concentrations of insulin
(0 ng/ml, 0.5 ng/ml, 1 ng/ml, and 1.5 ng/ml) above and below the expected
concentration in the skeletal muscle were used. The insulin solutions were
added to the perfusate, and the net changes in the concentrations of the ana-
lytes in the dialysate were recorded (insulinout  insulinin = net change).
Regression analysis yielded a linear relationship between the concentrations
in the perfusates and the dialysates. The intercept with the x axis indicates
the insulin concentrations in the perfusate at equilibrium with the surrounding
medium, and the slope of the line yields the dialysis recovery by the no-net
flux technique. The insulin concentrations in the interstitial fluid were
calculated from the dialysis recovery by the no-net flux technique and the
in vivo dialysate insulin concentration, as described previously (Sjostrand
et al., 2002).ll Metabolism 13, 294–307, March 2, 2011 ª2011 Elsevier Inc. 305
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The aorta was dissected out from the aortic arch to the abdominal aorta and
immersed in 10% FBS-DMEM containing 1000 U/ml heparin. A 24-gauge
cannula was inserted into the proximal portion of the aorta. The other side
was tied, and the lumen was filled with a solution of collagenase type II
(2 mg/ml, dissolved in serum-free DMEM). After incubation at 37C for
45 min, the endothelial cells were removed from the aorta by flushing with
5 ml of DMEM containing 10% FBS and cultured in a 35 mm collagen type
1-coated dish. Further information is provided in the Supplemental
Information.
Hyperinsulinemic-Euglycemic Clamp
An infusion catheter was inserted into the right jugular vein of the mice, as
described previously (Kubota et al., 2008), with some modifications. 1%
glucose ([6,6-2H2]glucose [Sigma]) was infused intravenously, and after
a 90 min basal period a blood sample was collected from the tail tip for deter-
mination of the basal glucose specific activity. To measure the GIR, a primed-
continuous infusion of insulin (Humulin R; Lilly) was administered and the blood
glucose concentration was maintained at approximately 120 mg/dl by the
administration of glucose (5 g of glucose/10 ml enriched to about 20% with
[6,6-2H2]glucose [Sigma]) for 60 or 120 min. Blood samples (20 ml) were
obtained for 15 or 30 min before the end of the hyperinsulinemic-euglycemic
clamp. Thereafter, the Rdwas calculated according to non-steady-state equa-
tions, and the EGP was calculated as the difference between the Rd values
and the exogenous GIR. Further information is provided in the Supplemental
Information.
Statistical Analysis
Values were expressed as means ± SEM. Student’s t test was used for statis-
tical analysis of the differences between two groups, and the statistical signif-
icance of differences among multiple groups was determined by ANOVA.SUPPLEMENTAL INFORMATION
Supplemental Information includes six figures, one movie, Supplemental
Experimental Procedures, and Supplemental References and can be found
with this article at doi:10.1016/j.cmet.2011.01.018.
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